140 related articles for article (PubMed ID: 3829049)
41. Comparison of the binding parameters to melanoma cells of antihuman high molecular weight-melanoma associated antigen (HMW-MAA) monoclonal antibodies (mAb) and syngeneic anti-anti-idiotypic (anti-anti-id) mAb.
Chen ZJ; Ferrone S
Ann N Y Acad Sci; 1993 Aug; 690():398-401. PubMed ID: 8368768
[No Abstract] [Full Text] [Related]
42. Discrepancy Between Tumor Antigen Distribution and Radiolabeled Antibody Binding in a Nude Mouse Xenograft Model of Human Melanoma.
Kim YI; Paeng JC; Cheon GJ; Kang KW; Lee DS; Chung JK
Cancer Biother Radiopharm; 2017 Apr; 32(3):83-89. PubMed ID: 28380302
[TBL] [Abstract][Full Text] [Related]
43. Difference in cell binding patterns of two monoclonal antibodies recognizing distinct epitopes on a human melanoma-associated oncofetal antigen.
Liao SK; Khosravi MJ; Brown JP; Kwong PC
Mol Immunol; 1987 Jan; 24(1):1-9. PubMed ID: 2441244
[TBL] [Abstract][Full Text] [Related]
44. In vivo tumor localization using tumor-specific monkey xenoantibody, alloantibody, and murine monoclonal xenoantibody.
Stuhlmiller GM; Sullivan DC; Vervaert CE; Croker BP; Harris CC; Seigler HF
Ann Surg; 1981 Nov; 194(5):592-601. PubMed ID: 6895297
[TBL] [Abstract][Full Text] [Related]
45. Immunoreactivity assay for labeled anti-melanoma monoclonal antibodies.
Beaumier PL; Neuzil D; Yang HM; Noll EA; Kishore R; Eary JF; Krohn KA; Nelp WB; Hellström KE; Hellström I
J Nucl Med; 1986 Jun; 27(6):824-8. PubMed ID: 3712094
[TBL] [Abstract][Full Text] [Related]
46. Comparison of the pharmacokinetics, biodistribution and dosimetry of monoclonal antibodies OC125, OV-TL 3, and 139H2 as IgG and F(ab')2 fragments in experimental ovarian cancer.
Molthoff CF; Pinedo HM; Schlüper HM; Nijman HW; Boven E
Br J Cancer; 1992 May; 65(5):677-83. PubMed ID: 1586596
[TBL] [Abstract][Full Text] [Related]
47. Human IgM monoclonal anti-GD2 antibody: reactivity to a human melanoma xenograft.
Katano M; Saxton RE; Tsuchida T; Irie RF
Jpn J Cancer Res; 1986 Jun; 77(6):584-94. PubMed ID: 3089993
[TBL] [Abstract][Full Text] [Related]
48. Melanocyte lineage-specific antigens recognized by monoclonal antibodies NKI-beteb, HMB-50, and HMB-45 are encoded by a single cDNA.
Adema GJ; de Boer AJ; van 't Hullenaar R; Denijn M; Ruiter DJ; Vogel AM; Figdor CG
Am J Pathol; 1993 Dec; 143(6):1579-85. PubMed ID: 7504884
[TBL] [Abstract][Full Text] [Related]
49. Specific localization, gamma camera imaging, and intracellular trafficking of radiolabelled chimeric anti-G(D3) ganglioside monoclonal antibody KM871 in SK-MEL-28 melanoma xenografts.
Lee FT; Rigopoulos A; Hall C; Clarke K; Cody SH; Smyth FE; Liu Z; Brechbiel MW; Hanai N; Nice EC; Catimel B; Burgess AW; Welt S; Ritter G; Old LJ; Scott AM
Cancer Res; 2001 Jun; 61(11):4474-82. PubMed ID: 11389078
[TBL] [Abstract][Full Text] [Related]
50. Studies of a high molecular weight human melanoma-associated antigen.
Hellström I; Garrigues HJ; Cabasco L; Mosely GH; Brown JP; Hellström KE
J Immunol; 1983 Mar; 130(3):1467-72. PubMed ID: 6822741
[TBL] [Abstract][Full Text] [Related]
51. Analysis of the interaction between a human high molecular weight melanoma-associated antigen and the monoclonal antibodies to three distinct antigenic determinants.
Giacomini P; Natali P; Ferrone S
J Immunol; 1985 Jul; 135(1):696-702. PubMed ID: 2582052
[TBL] [Abstract][Full Text] [Related]
52. Expression of adaptor protein Ruk/CIN85 isoforms in cell lines of various tissue origins and human melanoma.
Mayevska O; Shuvayeva H; Igumentseva N; Havrylov S; Basaraba O; Bobak Y; Barska M; Volod'ko N; Baranska J; Buchman V; Drobot L
Exp Oncol; 2006 Dec; 28(4):275-81. PubMed ID: 17285110
[TBL] [Abstract][Full Text] [Related]
53. Monoclonal antibodies derived from immunosuppressed mice grafted with human melanoma.
Herlyn D; Atkinson B; Koprowski H
J Immunol Methods; 1983 Feb; 57(1-3):155-64. PubMed ID: 6827100
[TBL] [Abstract][Full Text] [Related]
54. Inhibition of human tumor growth by IgG2A monoclonal antibodies correlates with antibody density on tumor cells.
Herlyn D; Powe J; Ross AH; Herlyn M; Koprowski H
J Immunol; 1985 Feb; 134(2):1300-4. PubMed ID: 3965572
[TBL] [Abstract][Full Text] [Related]
55. Surface antigens of melanomas and melanocytes defined by mouse monoclonal antibodies: specificity analysis and comparison of antigen expression in cultured cells and tissues.
Real FX; Houghton AN; Albino AP; Cordon-Cardo C; Melamed MR; Oettgen HF; Old LJ
Cancer Res; 1985 Sep; 45(9):4401-11. PubMed ID: 4028024
[TBL] [Abstract][Full Text] [Related]
56. Antiangiogenic therapy of established tumors in human skin/severe combined immunodeficiency mouse chimeras by anti-endoglin (CD105) monoclonal antibodies, and synergy between anti-endoglin antibody and cyclophosphamide.
Takahashi N; Haba A; Matsuno F; Seon BK
Cancer Res; 2001 Nov; 61(21):7846-54. PubMed ID: 11691802
[TBL] [Abstract][Full Text] [Related]
57. Kinetics of cellular trafficking and cytotoxicity of 9.2.27-gelonin immunotoxins targeted against the high-molecular-weight melanoma-associated antigen.
Chan MC; Murphy RM
Cancer Immunol Immunother; 1999 Feb; 47(6):321-9. PubMed ID: 10203062
[TBL] [Abstract][Full Text] [Related]
58. Bispecific-antibody-mediated targeting of radiolabeled bivalent haptens: theoretical, experimental and clinical results.
Le Doussal JM; Barbet J; Delaage M
Int J Cancer Suppl; 1992; 7():58-62. PubMed ID: 1428406
[TBL] [Abstract][Full Text] [Related]
59. Light chain variants of an IgG3 anti-GD3 monoclonal antibody and the relationship among avidity, effector functions, tumor targeting, and antitumor activity.
Chapman PB; Lonberg M; Houghton AN
Cancer Res; 1990 Mar; 50(5):1503-9. PubMed ID: 2105840
[TBL] [Abstract][Full Text] [Related]
60. Tissue specificity of anti melanoma monoclonal antibodies analyzed on cell lines.
Johnson JP; Riethmüller G
Hybridoma; 1982; 1(4):381-5. PubMed ID: 6208134
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]